Suppr超能文献

健康年轻人体内肠外甲状旁腺激素-(1-34)[PTH-(1-34)]与甲状旁腺激素相关肽-(1-34)的药代动力学比较。

Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.

作者信息

Fraher L J, Klein K, Marier R, Freeman D, Hendy G N, Goltzman D, Hodsman A B

机构信息

Department of Medicine, Lawson Research Institute, St. Joseph's Health Center, London, Ontario, Canada.

出版信息

J Clin Endocrinol Metab. 1995 Jan;80(1):60-4. doi: 10.1210/jcem.80.1.7829640.

Abstract

The amino-terminal fragments of human PTH [hPTH-(1-34)] and PTH-related peptide [PTHrP-(1-34)] appear to be equipotent in several rodent models. However, continuous i.v. infusions of these peptides to young human volunteers suggested that a 10-fold higher molar dose of PTHrP was required to produce comparable circulating levels of the peptide and biochemical responses similar to PTH. As PTHrP has a wide variety of target tissues in mammalian species and may, therefore, play a paracrine, rather than an endocrine, hormonal role in vivo, we evaluated whether enhanced metabolic clearance of injected PTHrP might explain its apparently reduced potency as a PTH-like hormone. Ten healthy subjects [age, 25 +/- 9 (+/- SD) yr] received in random order either hPTH-(1-34) or hPTHrP-(1-34) given by bolus i.v. injections in a dose of 10.7 nmol. Measurements of plasma immunoreactive peptide indicated a comparable volume of distribution for each, but the apparent t1/2 (8.3 +/- 1.6 min) and plasma clearance (4.0 +/- 1.4 L/min) for hPTHrP were significantly (P < 0.05) accelerated compared to those of hPTH (t1/2, 10.2 +/- 0.5 min; clearance, 2.0 +/- 0.4 L/min). Peak plasma cAMP levels were 9-fold lower in response to hPTHrP (29.5 +/- 19 vs. 190 +/- 63 pmol/L; P < 0.01), and increases in urinary cAMP excretion were 5-fold lower (2.1 +/- 1.1 vs. 11.2 +/- 3.7 nmol/mmol creatinine; P < 0.01). No major differences were observed in the urinary excretion of phosphate, calcium, or sodium between the two peptides. Although hPTHrP-(1-34) has a 2-fold higher MCR than hPTH-(1-34), this may not explain the more than 5-fold lower plasma or urinary cAMP response to PTHrP in humans. The comparable effects of PTH and PTHrP on urinary phosphate, calcium, and sodium may indicate a non-cAMP-dependent pathway for these responses, although the intracellular pool of cAMP generated to either peptide, and thus the local target tissue response, could not be estimated in the present study.

摘要

人甲状旁腺激素[hPTH-(1-34)]和甲状旁腺激素相关肽[PTHrP-(1-34)]的氨基末端片段在几种啮齿动物模型中似乎具有同等效力。然而,对年轻人类志愿者持续静脉输注这些肽表明,需要10倍摩尔剂量更高的PTHrP才能产生与PTH相当的循环肽水平和类似的生化反应。由于PTHrP在哺乳动物物种中有多种靶组织,因此可能在体内发挥旁分泌而非内分泌激素的作用,我们评估了注射的PTHrP代谢清除增强是否可以解释其作为类PTH激素时效力明显降低的原因。10名健康受试者[年龄,25±9(±标准差)岁]以随机顺序接受静脉推注10.7 nmol剂量的hPTH-(1-34)或hPTHrP-(1-34)。血浆免疫反应性肽的测量表明两者的分布容积相当,但与hPTH相比,hPTHrP的表观t1/2(8.3±1.6分钟)和血浆清除率(4.0±1.4升/分钟)显著加快(P<0.05)[hPTH的t1/2为10.2±0.5分钟;清除率为2.0±0.4升/分钟]。hPTHrP引起的血浆cAMP峰值水平低9倍(29.5±19对190±63 pmol/L;P<0.01),尿cAMP排泄增加低5倍(2.1±1.1对11.2±3.7 nmol/mmol肌酐;P<0.01)。两种肽之间在尿磷酸盐、钙或钠的排泄方面未观察到主要差异。尽管hPTHrP-((1-34)的MCR比hPTH-(1-34)高2倍,但这可能无法解释人类对PTHrP的血浆或尿cAMP反应降低超过5倍的原因。PTH和PTHrP对尿磷酸盐、钙和钠的类似作用可能表明这些反应存在非cAMP依赖性途径,尽管本研究无法估计两种肽产生的细胞内cAMP池以及因此局部靶组织的反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验